PubRank

Bouke C de Jong

Author PubWeight™ 43.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2006 8.90
2 Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2007 3.32
3 Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol 2013 2.89
4 A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med 2014 2.39
5 Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 2007 2.36
6 Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008 1.79
7 Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS One 2007 1.45
8 Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 2010 1.45
9 Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis 2011 1.38
10 The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex. PLoS Negl Trop Dis 2012 1.20
11 Mycobacterium africanum: a new opportunistic pathogen in HIV infection? AIDS 2005 1.13
12 Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One 2010 1.09
13 Identification of probable early-onset biomarkers for tuberculosis disease progression. PLoS One 2011 1.00
14 Insertion sequence element single nucleotide polymorphism typing provides insights into the population structure and evolution of Mycobacterium ulcerans across Africa. Appl Environ Microbiol 2013 0.98
15 Effects of cryopreservation on CD4+ CD25+ T cells of HIV-1 infected individuals. J Clin Lab Anal 2008 0.95
16 Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo. PLoS Negl Trop Dis 2011 0.95
17 Impaired fitness of Mycobacterium africanum despite secretion of ESAT-6. J Infect Dis 2012 0.92
18 The first phylogeographic population structure and analysis of transmission dynamics of M. africanum West African 1--combining molecular data from Benin, Nigeria and Sierra Leone. PLoS One 2013 0.92
19 Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo. PLoS Negl Trop Dis 2013 0.88
20 Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia. Emerg Infect Dis 2013 0.88
21 Deciphering the growth behaviour of Mycobacterium africanum. PLoS Negl Trop Dis 2013 0.86
22 AdvISER-PYRO: Amplicon Identification using SparsE Representation of PYROsequencing signal. Bioinformatics 2013 0.85
23 Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients. Eur J Immunol 2014 0.83
24 Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru. BMC Infect Dis 2013 0.80
25 Supervised learning for the automated transcription of spacer classification from spoligotype films. BMC Bioinformatics 2009 0.80
26 Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia. PLoS One 2012 0.79
27 Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia. Clin Infect Dis 2013 0.76
28 Catch them while you can! Am J Respir Crit Care Med 2008 0.75
29 Correction: Whole Genome Comparisons Suggest Random Distribution of Mycobacterium ulcerans Genotypes in a Buruli Ulcer Endemic Region of Ghana. PLoS Negl Trop Dis 2015 0.75